We acquire, market and develop a portfolio of mature branded medicines globally

What we do

Pill icon


We acquire “mature” (i.e. post-patent expiry), established branded prescription medicines from large cap and specialty pharma.

Suitcase icon


We currently own and market a portfolio of more than 20 medicines and operate in more than 140 markets globally.

Beaker icon


We develop line extensions (new formulations or new markets) to the medicines we acquire. We also develop our own niche generic medicines in-house.

How we do it

Team icon


Our dedicated team of regulatory, artwork, technical and project management experts has vast experience in transitioning medicines seamlessly into our manufacturing and distribution networks, and working with vendors to ensure there is no disruption in supply to wholesalers, hospitals, pharmacies and ultimately – and most importantly – patients.

Line up icon

In Line

Once we have successfully transitioned an acquired medicine or launched a developed medicine, our In Line team takes over the life cycle management of the medicines, making sure we maintain the highest standard of ethical medical practice, manage our supply chain effectively and responsibly and deliver high-quality medicines to our patients.

Microscope icon

Product Development

Our chemists work with our regulatory, artwork and technical experts to make the most of the medicines we acquire, developing new formulations for new markets. They also work on developing and launching generic medicines for niche indications.

Our key therapeutic areas

Man in his 50s smiling


Our key products include, Inderal®, Tenormin®, Tenoretic®, Zestril®and Zestoretic®


Women’s Health & Endocrinology

Our key products include, Bonviva®, Rocaltrol®, Synacthen® and Traxidot®

Man holding wrist in pain

Neurology & Pain

Our key products include, Anaprox®, Naprosyn®, Toradol® and Valium®

Bald woman smiling

Gastroenterology & Oncology

Our key products include, Bondronat®, Dipentum® and Kytril®

Illustration of a box 20+ Brands
Illustration of a group of people 120+ Employees
Illustration of a globe with a map marker 140+ Markets
Illustration of a box 1,200+ Marketing Authorisations

Our markets and offices

We partner with distribution partners to offer as wide a market coverage as possible. Our network now covers over 140 markets. We have offices in Basildon, London, Copenhagen, Dubai, Sydney and Vadodara.

  • Our markets
  • Map pin icon Our offices
Map of Atnahs distribution markets and offices

Our partnerships and memberships

We are proud to be a member of EMIG, the Ethical Medicines Industry Group. Learn more at emig.org.uk

Looking to license or divest a medicine?

Or are you a CMO or distributor who wishes to partner with us?

Get in touch